Laddar...

Antibodies to watch in 2010

Monoclonal antibodies (mAbs) are a burgeoning class of therapeutics, with more than 25 approved in countries worldwide. Novel molecules are entering clinical study at a rate of nearly 40 per year, and the commercial pipeline includes approximately 240 mAb therapeutics in clinical studies that have n...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: Reichert, Janice M
Materialtyp: Artigo
Språk:Inglês
Publicerad: Landes Bioscience 2010
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828582/
https://ncbi.nlm.nih.gov/pubmed/20065640
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!